|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets, net | ||||||||||||||||||||
| Product development costs, net of amortization of $1,052,322 and $833,452, respectively | ||||||||||||||||||||
| Software development costs | ||||||||||||||||||||
| Software development costs, net of amortization of $1,753,224 and $1,183,765, respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net of amortization of $7,570,999 and $7,190,101, respectively | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Series C Redeemable Preferred Stock | ||||||||||||||||||||
| Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 1 share issued and outstanding as of June 30, 2026 and December 31, 2025; aggregate liquidation preference of $2,000,000 as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Series C Redeemable Preferred Stock | ||||||||||||||||||||
| Total series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 1 share issued and outstanding as of June 30, 2026 and December 31, 2025; aggregate liquidation preference of $2,000,000 as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Series H Preferred Stock | ||||||||||||||||||||
| Common stock, par value $0.0001 per share: 800,000,000 shares authorized; 899,759 and 906,059 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity | ||||||||||||||||||||
Loading...